Melatonin precursor, L-tryptophan protects the pancreas from development of acute pancreatitis through the central site of action

Journal of Physiology and Pharmacology

Volumn 55, Issue 1 II, 2004, Pages 239-254

  Leja Szpak, A ^a   Jaworek, Jolanta ^a   Tomaszewska, R ^a   Nawrot, K ^a   Bonior, J ^a   Kot, M ^a   Palonek, M ^a   Stachura, J ^a   Czupryna, A ^a   Konturek, S J ^a   Pawlik, W W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

L tryptophan; Lipid peroxidation; Melatonin; Reactive oxygen species (ROS); Superoxide dismutase (SOD)

Indexed keywords

4 HYDROXYNONENAL; AMYLASE; CERULETIDE; MALONALDEHYDE; MELATONIN; MELATONIN DERIVATIVE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL LIPASE; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION; PANCREAS; PANCREAS INJURY; RAT; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; ALDEHYDES; AMYLASES; ANIMALS; CAERULEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INFUSIONS, PARENTERAL; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; LIPASE; MALE; MALONDIALDEHYDE; MELATONIN; ORGAN SIZE; PANCREAS; PANCREATITIS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRYPTOPHAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11144355897     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lerner AB, Case JD, Takahashi Y et al. Isolation of melatonin, pineal factor that ligtens melanocytes. J Am Chem Soc 1958; 80: 2587.
2. Sugden D. Melatonin biosynthesis in the mammalian pineal gland. Experientia 1989; 45: 922-931.
3. Zawilska JB, Nowak JZ. Regulatory mechnisms in melatonin biosynthesis in retina. Neurochem Int 1992; 20: 32-36.
4. Heuther G. Melatonin synthesis in the gastrointestinal tract and the impact of nutricial factors on circulating melatonin. Ann N Y Acad Sci USA 1994; 719: 146-158.
5. Bubenik GA. Gastrointestinal melatonin: localization, function and clinical relevance. Dig Dis Sci 2002; 47(10): 2336-2348.
6. Morgan PJ, Barrett P, Howell HE, Helliwell R. Melatonin receptor localisation, molecular pharmacology and physiological significance. Neurochem Int 1994; 24: 101-146.
7. Blumenau C, Berger E, Fauteck JD et al. Expression and functional characterisation of the mt1 melatonin receptor from rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol pathway. J Pineal Res 2001; 30(3): 139-146.
8. Yu ZH, Yuan H, Lu Y, Pang SF. 2-[125]-jodomelatonin bindings sites in spleens of birds and mammals. Neurosci Lett 1991; 125: 175-178.
9. Song Y, Tam PC, Poon AM et al. 2-[125]-jodomelatonin binding sites in the human kidney and the effect of guanosine 5′-O-(thiotriphosphate). J Clin Endocrinol Metab 1995; 80: 1560-1565.
10. Lee PP, Shiu SY, Chow PH, Pang SF. Regional and diurnal studies of melatonin and melatonin bindings sites in the duck gastro-intestinal tract. Biol Signals 1995; 4(4): 212-224.
11. Peschke E, Fauteck JD, Musshoff U et al. Evidence for melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic and molecular investigation. J Pineal Res 2000; 28(3): 156-164.
12. Peschke E, Peschke D. Evidence for circadian rhytm of insulin release from perfused rat pancreatic islets. Diabetology 1998; 41(9): 1085-1092.
13. Peschke E, Muhlbauer E, Musshoff U et al. Receptor MT 1 mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002; 3(2): 63-71.
14. Reiter RJ, Tang L, Garcia JJ, Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60(25): 2255-2271.
15. Pieri C, Moroni F, Marra M et al. Melatonin is an efficient antioxidant. Arch Gerontol Geriatics 1995; 20: 159-165.
16. Brzozowski T, Konturek PCh, Konturek SJ et al. The role of melatonin and L-tryptophan in prevention of acute gastric lesion induced by stress, ethanol, ischemia and aspirin. J Pineal Res 1997; 23: 79-89.
17. Jaworek J, Bonior J, Leja-Szpak A et al. Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin. J Physiol Pharmacol 2002; 53; 1: 51-74.
18. 2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolisaccharides. J Physiol Pharmacol 2001; 52: 107-126.
19. Jaworek J, Bonior J, Pierzchalski P et al. Leptin protects the pancreas from its damage induced by caerulein overstimulation by modulation of cytokine production. Pancreatology 2002; 2: 89-99.
20. 2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53(4): 791-804.
21. Jaworek J, Leja-Szpak A, Bonior J et al. Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003; 34(1): 40-52.
22. Guice KS, Miller DE, Oldham KT et al. Superoxide dismutase and catalase. A possible role in established pancreatitis. Am J Surg 1986; 151: 163-167.
23. Konturek PC, Konturek SJ, Brzozowski T et al. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischaemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997; 32(5): 433-438.
24. Kwieciefi S, Brzozowski T, Konturek PC, Pawlik MW, Kwieciefi N, Konturek SJ. The role of reactive oxygen species and capsaicin-sensitive sensory nerves in the pathomechanism of gastric ulcers induced by stress. J Physiol Pharmacol 2003; 54(3): 423-437.
25. Sanfey H, Bulkley GB, Cameron JL. The role of oxygen derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg 1984; 200: 405-413.
26. Da̧browski A, Konturek SJ, Konturek JW, Gabryelewicz A. Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol 1999; 377: 1-11.
27. Tan DX, Manchester LC, Reiter RJ et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998; 253: 614-620.
28. Reiter RJ, Tan DX, et al. The oxidant/antioxidant network: role of melatonin. Biol Signals Recept 1999b; 8: 53-63.
29. Watanabe S, Togashi S, Takakashi N, Fukui T. L-tryptophan as an antioxidant in human placenta extract. J Nutr Sci Vitaminol 2002; 48(1): 36-39.
30. Tan DX, Manchester LC, Reiter RJ et al. Melatonin supresses antioxidation and hydrogen peroxide-induced lipid peroxidation in monkey brain homogenate. Neuroendocrinol Lett 2000; 21(5): 361-365.
31. Burkart V, Koike TH, Brenner H, Kolb H. Oxygen radical generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro. Diabetologia 1992; 35: 1028-1034.
32. Kaneto H, Fujii J, Seo HG et al. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 1995; 44: 733-738.
33. Ebelt H, Peschke D, Bromme HJ et al. Influence of melatonin on free radical-induced changes in rat pancreatic beta-cells in vitro. J Pineal Res 2000; 28: 65-72.
34. Sanfey H, Bulkley GB, Cameron JL. The pathogenesis of acute pancreatitis: the source and role of oxygen derived free radicals in three different experimental models. Ann Surg 1985; 201: 633.
35. Kato K, Asai S, Murai I et al. Melatonin's gastroprotective and antistress roles involve both central and peripheral effects. J Gastroenterol 2001; 36: 91-95.
36. Rodriguez-Reynoso S, Leal C, Portilla E et al. Effect of exogenous melatonin on hepatic energetic status during ischemia-reperfusion: possible role of tumor necrosis factor alpha and nitric oxide. J Surg Res 2001; 100: 141-149.
37. Lissoni P. The pineal gland as a central regulator of cytokine network. Neuroendocrinol Lett 1999; 20(6): 343-349.
38. Sharman KG, Sharman EH, Yang E, Bondy SC. Dietary melatonin selectively reverses age-related changes in cortical cytokine mRNA levels, and their responses to an inflammatory stimulus. Neurobiol Aging 2002; 23(4): 633-638.
39. Shafer LL, McNulty JA, Young MR. Assessment of melatonin's ability to regulate cytokine production by macrophage and microglia cell types. J Neuroimmunol 2001; 120(1-2): 84-93.
40. Kulwein E, Irwin M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J Neuroimmunol 2001; 117(1-2): 51-57.